Admission Date:  [**2169-9-17**]              Discharge Date:   [**2169-9-26**]  Date of Birth:  [**2103-12-19**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 6180**] Chief Complaint: Weakness  Major Surgical or Invasive Procedure: Paracentesis Left Subclavian central line  History of Present Illness: Mr. [**Known lastname **] is a 65 yo male with metastatic hepatocellular carcinoma, on Xeloda therapy since early [**Month (only) 216**], who presented with fever and weakness.
His ascites had been increasing over last week even though he had had 3.5L drained 1 week ago and had lasix dose increased from 60 mg to 40mg.
In ED had temp to 98.0  P 80-97  BP 87/42  R18 Sat 97%on 3L, sepsis line placed, give 8L NS, diagnostic para done with 91WBC and given ceftriaxzone 1gm, vanc 1gm, and flagyl 500mg x1.
Started on levophed for BP support despite 8LNS.
Past Medical History: PMHx: 1) Oncologic:  Hepatocellular carcinoma diagnosed in [**2167**] after 1 year of RUQ abdominal pain, elevated AFP, and liver lesion noted on MRI  [**2167-5-13**] which revealed presence of a 1 x 1 cm lesion in segment 8 of the liver with evidence of portal hypertension, esophageal varices and splenomegaly.
In early [**2168**], however, he was admitted in [**Country 651**] for an episode of hepatic decompensation, and subsequently in [**9-17**] a CT abdomen showed a new 2.5 cm mass in the liver.
He left for [**Country 651**] at that point and was treated there with modalities that are uncertain.
Most recent CT on [**8-21**] demonstrated an increase in size of the liver lesion to 4 x 3 cm, also with increase in soft tissue component of L hip hematoma worrisome for metastatic disease.
Xeloda 500 b.i.d.
2) Hepatitis B 3) Nephrolithiasis 4) cholelithiasis 5) type II diabetes - Diet controlled 6) H/O Tuberculosis   Social History: Chinese immigrant, came to the US in early [**2163**].
Physical Exam: VS: T96.1  BP 91/49  P94  RR 18  SAt 96%on NRB  CVP 14  on levo 0.33 GEN aao, lethargic, jaundiced HEENT PERRL, +scleral icterus, dry MM CHEST CTAB, with decreased BS half way bilterally CV RRR, tachy no murmurs ABD soft, distended, +fluid wave, +TTP EXT 2+LE pitting bilateral edema, +asterixis, +4cm left hip hematoma  Pertinent Results: CXR: The left subclavian central venous catheter area remains in stable position with tip in the lower SVC.
He was transferred to the florr where a palliative care consult was obtained and he was started on IV morphine, maintained on supplemental oxygen and was made as comfortable as possible.
His respiratory status worsened and he was given IV morphine as needed for discomfort until the time of his death.
Medications on Admission: CROMOLYN SODIUM 40 MG/ML INTRANASAL [**1-15**] SPRAYS EACH NOSTRIL QDAY METHYLPHENIDATE 10 MG PO QAM TRAZODONE 25 MG PO QHS LASIX 60MG PO QDAY URSODIOL 300MG PO QDAY SPIRONOLACTONE 50 MG PO QDAY XELODA 500 MG PO BID 2 weeks on, 1 week off .
